RNA Clinical Trials Resources
-
Non-Small Cell Lung Cancer — Global Clinical Trial Landscape (2024)
7/3/2024
Explore cutting-edge Non-Small Cell Lung Cancer (NSCLC) research with Novotech CRO's in-depth disease analysis, providing insights into innovative therapies, clinical trials, and future directions shaping NSCLC care globally.
-
Liver Cancer — Global Clinical Trial Landscape (2024)
7/3/2024
Explore the latest advancements and clinical trial landscape in liver cancer research with Novotech CRO's comprehensive disease report.
-
South Korea And Australia On The Rise As Clinical Research Hubs
7/3/2024
Novotech’s vice president emphasizes the expanding clinical presence in the APAC region, with a focus on Australia and South Korea.
-
The Sponsor's Clinical Development Handbook For Gene Therapy Trials
6/21/2024
Gene therapy has existed for decades, but the field is not as mature as it may seem. Here, the author provides essential insights and strategies for overcoming gene therapy development challenges.
-
How To Unlock The Secret To Repeatable, Scalable Low Turnover
6/7/2024
Here, we explore the evolution of a 10-year partnership and extrapolate the principles that create cohesive teams and minimize turnover.
-
Overview Of Endometrial Cancer: Global Clinical Trials Landscape
5/17/2024
This FAQ delves into the latest developments in endometrial cancer treatment, highlighting innovative drugs, ongoing clinical trials, and their potential impact on patient outcomes.
-
Endometrial Cancer — Global Clinical Trial Landscape (2024)
5/17/2024
Enhance your knowledge of the latest advancements in endometrial cancer research with this CRO disease report, featuring new treatments, clinical trials, and future innovations in care.
-
Shifting The Approach: 4 Tactics For ICH E6(R3) Implementation
4/30/2024
In addition to codifying some best practices, R3 recommends that sponsors adopt an approach to identifying and managing areas of risk to mitigate potential issues and enhance overall success.
-
The Benefits Of Cas9 mRNA: Precision, Control, Cost Efficiency
4/26/2024
Unlock the full potential of CRISPR-Cas9 gene editing with high-purity Cas9 mRNA, the emerging choice for safer and more efficient genome engineering.
-
Global Prevalence And Clinical Trials Landscape Of AML
4/8/2024
Explore the advancements in Acute Myeloid Leukaemia treatments, specifically innovative drugs, ongoing clinical trials, and their potential impact on patient outcomes.